New combo attack on tough head and neck cancers
Disease control
Completed
This study tested whether adding a new immunotherapy drug (pembrolizumab) to the standard treatment of chemotherapy plus radiation could be safe and more effective for people with locally advanced head and neck cancer. All 59 participants received the combined treatment. The main…
Phase: PHASE1 • Sponsor: Sanford Health • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC